Microfluidics for diagnosis and treatment of cardiovascular disease. Issue 3 (21st December 2022)

• Record Type: Journal Article
• Authors: Ma, Yonggeng; Liu, Chenbin; Cao, Siyu; Chen, Tianshu; Chen, Guifang
• Is Part Of: Journal of materials chemistry. Volume 11:Issue 3(2022)
• Page Start: 546
• Page End: 559
• Publication Date: 2022-12-21
• Subjects: Materials -- Periodicals; Chemistry, Analytic -- Periodicals; Biomedical materials -- Research -- Periodicals; 543.0284
• DOI: 10.1039/d2tb02287g
• Languages: English
• ISSNs: 2050-750X

Abstract

Abstract : We have reviewed various recent applications of microfluidics in the clinical diagnosis and treatment of CVDs and presented the prospects and challenges of microfluidics in the diagnosis and treatment of CVDs. Abstract : Cardiovascular disease (CVD), a type of circulatory system disease related to the lesions of the cardiovascular system, has become one of the main diseases that endanger human health. Currently, the clinical diagnosis of most CVDs relies on a combination of imaging technology and blood biochemical test. However, the existing technologies for diagnosis of CVDs still have limitations in terms of specificity, detection range, and cost. In order to break through the current bottleneck, microfluidic with the advantages of low cost, simple instruments and easy integration, has been developed to play an important role in the early prevention, diagnosis and treatment of CVDs. Here, we have reviewed the recent various applications of microfluidic in the clinical diagnosis and treatment of CVDs, including microfluidic devices for detecting CVD markers, the cardiovascular models based on microfluidic, and the microfluidic used for CVDs drug screening and delivery. In addition, we have briefly looked forward to the prospects and challenges of microfluidics in diagnosis and treatment of CVDs.